MAPT and Alzheimer disease: Contributions of ApoE4 to AD progression are well established, and recent work indicates important roles for the low-density lipoprotein receptor (LDLR) and LDLR-related protein 1 (LRP1) in regulating tau uptake and spread, establishing important roles for lipid regulators in AD progression and possible therapeutic targets [49,50,51].